Evidence map›Paper›PMID 41661986›Full record

ArticlePLOS mental health2025

Standardized effect sizes are far from "Standardized": A primer and empirical illustration in depression psychotherapy meta-analyses.

Mathias Harrer, Clara Miguel, Yan Luo, Edoardo G Ostinelli, Eirini Karyotaki, Stefan Leucht, Toshi A Furukawa, Pim Cuijpers

Abstract read
In one paragraph

Article in PLOS mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mathias HarrerDepartment of Clinical, Neuro and Developmental Psychology, World Health Organization Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-7016-2687
Clara MiguelDepartment of Clinical, Neuro and Developmental Psychology, World Health Organization Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.
Yan LuoDepartment of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan.
Edoardo G OstinelliDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Eirini KaryotakiDepartment of Clinical, Neuro and Developmental Psychology, World Health Organization Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.
Stefan LeuchtSection for Evidence-Based Medicine in Psychiatry and Psychotherapy, Department of Psychiatry and Psychotherapy, School of Medicine and Health, German Center for Mental Health (partner site Munich-Augsburg), Technical University of Munich, Munich, Germany.
Toshi A FurukawaKyoto University Office of Institutional Advancement and Communications, Kyoto, Japan.ORCID https://orcid.org/0000-0003-2159-3776
Pim CuijpersDepartment of Clinical, Neuro and Developmental Psychology, World Health Organization Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-5497-2743

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Standardized mean differences (SMDs) are frequently used to appraise the effects of psychological treatments, and to combine them in meta-analyses. Yet, there is no consensus on how exactly SMDs should be computed from randomized trials. In this study, we show that different SMD variants can heavily diverge in aggregate-data meta-analyses, subverting the original purpose of standardization. We investigate the impact this has on the estimated benefits of depression psychotherapies. Different SMD versions using endpoint or change scores were calculated from a comprehensive database of randomized trials, comparing depression psychotherapy against pharmacotherapy and inactive controls. Pooled treatment effects were obtained for each variant, assuming correlations between baseline and endpoint scores of 0.2 through 0.8, and their relationship was examined using bivariate meta-analyses. We also investigated which study characteristics predicted divergent effect estimates. A total of k = 443 trials with 48,221 participants were analyzed. The pooled effect of psychotherapy versus controls varied heavily depending on the calculation methods (SMD = 0.65-1.24), even though the same studies were used. Divergences were less pronounced for psychotherapies compared to pharmacotherapy (SMD = 0.05-0.14). Change score SMDs deviated from endpoint SMDs especially when high (r = 0.8) or low (r = 0.2) pre-post correlations were assumed. This difference was largest in subfields with high treatment effects. Different SMD calculation methods can lead to strongly diverging effect estimates of psychological treatment; especially when change scores are used and pre-post correlations are very high or low. This could have a profound impact on how treatment benefits are interpreted within and across meta-analyses. Researchers could prioritize endpoint SMDs of randomized trials, and should consider standardization using population-level estimates to improve the comparability of meta-analytic effects in the field. Open Material; Registration: htpps://doi.org/10.5281/zenodo.10694719; https://osf.io/yx5jg; https://osf.io/4j23t.

Identifiers

PMID41661986
PMCPMC12798590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.